SCHEMBL7554063

SCHEMBL7554063

CCC(Cl)OCc1cccc([N+](=O)[O-])c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
MAOB P27338 2/20 0.49
MAOA P21397 1/20 0.49
FFAR1 O14842 1/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP1A2 P05177 1/20 0.48
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
MAPT P10636 4/20 0.45
LMNA P02545 1/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CA12 O43570 1/20 0.44
RECQL P46063 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6632275 0.83 MAOB (0.52) TSHRMAOBMAOAFFAR1CYP2D6
SCHEMBL11214531 0.82 TSHR (0.56) TSHRMAOBMAOAFFAR1CYP2D6
SCHEMBL3705262 0.79 TSHR (0.56) TSHRMAOBMAOAFFAR1CYP2D6
SCHEMBL791926 0.78 TSHR (0.62) TSHRMAOBMAOACYP2D6CYP2C9
SCHEMBL3721964 0.77 TSHR (0.57) TSHRMAOBMAOAFFAR1CYP2D6
SCHEMBL9628070 0.77 TSHR (0.66) TSHRMAOBMAOAKMT2AMEN1
SCHEMBL1767329 0.76 TSHR (0.65) TSHRMAOBMAOACYP2D6CYP2C9
SCHEMBL9506289 0.76 TSHR (0.49) TSHRMAOBMAOAFFAR1CYP2D6
SCHEMBL15716420 0.75 TSHR (0.55) TSHRMAOBMAOACYP2D6CYP2C9
SCHEMBL28008405 0.75 TSHR (0.59) TSHRMAOBMAOACYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214288-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE Targacept Inc. (US) 2002-06-19 EP disclosed
WO-2001017943-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE TARGACEPT, INC. (US) 2001-03-15 WO disclosed
EP-1042274-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE R.J. REYNOLDS TOBACCO COMPANY (US) 2000-10-11 EP disclosed
WO-2000023418-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE R.J. REYNOLDS TOBACCO COMPANY (US) 2000-04-27 WO disclosed